KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments

Posted on Mar 02, 2021, 3 p.m.


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.


The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta-lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.  


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta-lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://www.worldhealth.net/news/antibiotic-tolerance-study-paves-way-new-treatments/


List of Articles
번호 제목 글쓴이 날짜 조회 수
333 서성배 교수님_Gut hormone triggers craving for more proteins 생명과학과 2021.05.18 17
332 손종우 교수님_비정형 항정신병 약물에 의한 비만의 원인 규명​ 생명과학과 2021.05.17 34
331 서성배 교수님_동물의 식습관을 조절하는 원리 규명해 네이처 게재​ 생명과학과 2021.05.11 49
330 손종우교수님 UTSW – UT Dallas 국제 공동 연구팀 연구성과_Scientists Identify Source of Weight Gain From Antipsychotics 생명과학과 2021.05.14 62
329 김대수 교수님_ 카이스트 교수 `뇌 과학이 인생에 필요한 순간`(브라이트) 출간 생명과학과 2021.05.04 138
328 조병관교수님_온실가스를 바이오 물질로 전환…미생물 활용한 '인공광합성' 성공 생명과학과 2021.03.10 257
327 KAIST-원진 세포치료센터 기부 및 투자 약정 업무협약식 생명과학과 2021.02.22 295
» 조병관 교수님_Antibiotic tolerance study paves way for new treatments 생명과학과 2021.03.03 301
325 김진우 교수님, 천주교 서울대교구 생명위원회 제 15회 '생명의 신비상' 수상 생명과학과 2021.02.18 334
324 허원도 교수님(유다슬이 박사)_제10회 에쓰-오일 우수학위논문상'의 생명과학 분야 대상 수상 생명과학과 2021.02.22 338
323 서성배 교수님(양대욱 박사)_세종과학펠로우십 선정 생명과학과 2021.03.18 351
322 서성배 교수님(김진은 석박사통합과정)_2020 대한민국 인재상 수상 생명과학과 2021.02.25 406
321 정원석 교수님_국내 연구진, 우리 뇌가 계속 일할 수 있는 이유 밝혀 생명과학과 2021.02.26 412
320 김찬혁 교수님_인공지능 이용 면역항암 세포 3차원 분석기술 개발 생명과학과 2021.02.08 430
319 오병하 교수님_자연에 없는 고감도 단백질 센서 제작 플랫폼 개발 생명과학과 2021.02.08 440
318 김대수 교수님_스트레스로 악화 '근긴장이상증' 억제 신약 개발…수술없는 약물치료 기대 생명과학과 2021.03.11 478
317 조병관 교수님_Antibiotic tolerance study paves way for new treatments 생명과학과 2021.02.19 487
316 김진우 교수님_생명의 신비상 장려상 수상 생명과학과 2020.12.24 599
315 전상용 교수님_Researchers review future directions of nanomedicine development 생명과학과 2020.12.28 697
314 정인경 교수님_KAIST, 전 세계 최대 규모의 3차원 암 게놈 지도 구축 생명과학과 2020.12.29 898
Board Pagination Prev 1 2 3 4 5 6 7 8 9 10 ... 17 Next
/ 17